Evaluation of the Relevance of Pharmacogenetics in the Prescription Off Antidepressants in a Military Population

Last updated: April 27, 2023
Sponsor: Direction Centrale du Service de Santé des Armées
Overall Status: Active - Recruiting

Phase

N/A

Condition

Depression

Post-traumatic Stress Disorders

Treatment

N/A

Clinical Study ID

NCT04987047
2021RC01
2021-A00809-32
  • Ages 18-65
  • All Genders

Study Summary

The treatment of depression, anxiety disorders and post-traumatic stress disorder (PTSD) is a main public health problem due to the frequency of these pathologies and the very partial effectiveness of the existent therapies. These illnesses generally require the prescription of several successive lines of antidepressant treatments before the treatments actually become effective, leading to a several week delay during which the patient suffers from the symptoms of his/her pathology and is also likely to experience the side effects of the treatment.

Pharmacogenetics is an individualized prescribing modality that aims to predict the most favorable treatment for a given individual based on the study of genetic variants of cytochromes.

The main hypothesis of this research is that the use of pharmacogenetics in routine practice in a population of military personnel requiring a first prescription of an antidepressant is of interest to improve the tolerance and effectiveness of the treatment.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Between 18 and 65 years-old;
  • To benefit from a medical follow-up in the psychiatric department of an army traininghospital;
  • To present a pathology requiring an antidepressant treatment and whose prescriptioncan wait 10 days;
  • To have given written informed consent to participate in the study.

Exclusion

Exclusion Criteria:

  • To be currently treated with an antidepressant or antidepressant stopped less than 15days ago;
  • To have one or more contraindication to the introduction of an antidepressanttreatment;
  • Pregnancy or breastfeeding;
  • To require a measure of constraint.

Study Design

Total Participants: 250
Study Start date:
November 08, 2021
Estimated Completion Date:
November 30, 2025

Connect with a study center

  • Hôpital d'Instruction des Armées Percy

    Clamart, 92141
    France

    Active - Recruiting

  • Hôpital d'Instruction des Armées Laveran

    Marseille, 13384
    France

    Site Not Available

  • Hôpital d'Instruction des Armées Bégin

    Saint-Mandé, 94160
    France

    Active - Recruiting

  • Hôpital d'Instruction des Armées Sainte-Anne

    Toulon, 83000
    France

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.